Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis

The Notch signaling pathway is a critical player in embryogenesis but also plays various roles in tumorigenesis, with both tumor suppressor and oncogenic activities. Mutations, deletions, amplifications, or over-expression of Notch receptors, ligands, and a growing list of downstream Notch-activated...

Full description

Bibliographic Details
Main Authors: Julia O. Misiorek, Alicja Przybyszewska-Podstawka, Joanna Kałafut, Beata Paziewska, Katarzyna Rolle, Adolfo Rivero-Müller, Matthias Nees
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/1/94
id doaj-d7367b4cb6fe4ba8a01dd4c3d2cfdc56
record_format Article
spelling doaj-d7367b4cb6fe4ba8a01dd4c3d2cfdc562021-01-08T00:03:25ZengMDPI AGCells2073-44092021-01-0110949410.3390/cells10010094Context Matters: NOTCH Signatures and Pathway in Cancer Progression and MetastasisJulia O. Misiorek0Alicja Przybyszewska-Podstawka1Joanna Kałafut2Beata Paziewska3Katarzyna Rolle4Adolfo Rivero-Müller5Matthias Nees6Department of Molecular Neurooncology, Institute of Bioorganic Chemistry Polish Academy of Sciences, ul. Noskowskiego 12/14, 61-704 Poznan, PolandDepartment of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, PolandDepartment of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, PolandDepartment of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, PolandDepartment of Molecular Neurooncology, Institute of Bioorganic Chemistry Polish Academy of Sciences, ul. Noskowskiego 12/14, 61-704 Poznan, PolandDepartment of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, PolandDepartment of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, PolandThe Notch signaling pathway is a critical player in embryogenesis but also plays various roles in tumorigenesis, with both tumor suppressor and oncogenic activities. Mutations, deletions, amplifications, or over-expression of Notch receptors, ligands, and a growing list of downstream Notch-activated genes have by now been described for most human cancer types. Yet, it often remains unclear what may be the functional impact of these changes for tumor biology, initiation, and progression, for cancer therapy, and for personalized medicine. Emerging data indicate that Notch signaling can also contribute to increased aggressive properties such as invasion, tumor heterogeneity, angiogenesis, or tumor cell dormancy within solid cancer tissues; especially in epithelial cancers, which are in the center of this review. Notch further supports the “stemness” of cancer cells and helps define the stem cell niche for their long-term survival, by integrating the interaction between cancer cells and the cells of the tumor microenvironment (TME). The complexity of Notch crosstalk with other signaling pathways and its roles in cell fate and trans-differentiation processes such as epithelial-to-mesenchymal transition (EMT) point to this pathway as a decisive player that may tip the balance between tumor suppression and promotion, differentiation and invasion. Here we not only review the literature, but also explore genomic databases with a specific focus on Notch signatures, and how they relate to different stages in tumor development. Altered Notch signaling hereby plays a key role for tumor cell survival and coping with a broad spectrum of vital issues, contributing to failed therapies, poor patient outcome, and loss of lives.https://www.mdpi.com/2073-4409/10/1/94Notch signaling pathwaytumor progressiononcogenic mutationstumor suppressor genegain and loss of function mutations (GOF and LOF)epithelial-mesenchymal transition (EMT), angiogenesis
collection DOAJ
language English
format Article
sources DOAJ
author Julia O. Misiorek
Alicja Przybyszewska-Podstawka
Joanna Kałafut
Beata Paziewska
Katarzyna Rolle
Adolfo Rivero-Müller
Matthias Nees
spellingShingle Julia O. Misiorek
Alicja Przybyszewska-Podstawka
Joanna Kałafut
Beata Paziewska
Katarzyna Rolle
Adolfo Rivero-Müller
Matthias Nees
Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
Cells
Notch signaling pathway
tumor progression
oncogenic mutations
tumor suppressor gene
gain and loss of function mutations (GOF and LOF)
epithelial-mesenchymal transition (EMT), angiogenesis
author_facet Julia O. Misiorek
Alicja Przybyszewska-Podstawka
Joanna Kałafut
Beata Paziewska
Katarzyna Rolle
Adolfo Rivero-Müller
Matthias Nees
author_sort Julia O. Misiorek
title Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
title_short Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
title_full Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
title_fullStr Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
title_full_unstemmed Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis
title_sort context matters: notch signatures and pathway in cancer progression and metastasis
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2021-01-01
description The Notch signaling pathway is a critical player in embryogenesis but also plays various roles in tumorigenesis, with both tumor suppressor and oncogenic activities. Mutations, deletions, amplifications, or over-expression of Notch receptors, ligands, and a growing list of downstream Notch-activated genes have by now been described for most human cancer types. Yet, it often remains unclear what may be the functional impact of these changes for tumor biology, initiation, and progression, for cancer therapy, and for personalized medicine. Emerging data indicate that Notch signaling can also contribute to increased aggressive properties such as invasion, tumor heterogeneity, angiogenesis, or tumor cell dormancy within solid cancer tissues; especially in epithelial cancers, which are in the center of this review. Notch further supports the “stemness” of cancer cells and helps define the stem cell niche for their long-term survival, by integrating the interaction between cancer cells and the cells of the tumor microenvironment (TME). The complexity of Notch crosstalk with other signaling pathways and its roles in cell fate and trans-differentiation processes such as epithelial-to-mesenchymal transition (EMT) point to this pathway as a decisive player that may tip the balance between tumor suppression and promotion, differentiation and invasion. Here we not only review the literature, but also explore genomic databases with a specific focus on Notch signatures, and how they relate to different stages in tumor development. Altered Notch signaling hereby plays a key role for tumor cell survival and coping with a broad spectrum of vital issues, contributing to failed therapies, poor patient outcome, and loss of lives.
topic Notch signaling pathway
tumor progression
oncogenic mutations
tumor suppressor gene
gain and loss of function mutations (GOF and LOF)
epithelial-mesenchymal transition (EMT), angiogenesis
url https://www.mdpi.com/2073-4409/10/1/94
work_keys_str_mv AT juliaomisiorek contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT alicjaprzybyszewskapodstawka contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT joannakałafut contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT beatapaziewska contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT katarzynarolle contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT adolforiveromuller contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
AT matthiasnees contextmattersnotchsignaturesandpathwayincancerprogressionandmetastasis
_version_ 1724345885337321472